Sangamo Therapeutics Inc (SGMO) — Capital Reinvestment Ratio
Sangamo Therapeutics Inc (SGMO) has a Capital Reinvestment Ratio of 0.01x as of September 2024, meaning it reinvests 0% of its operating cash flow ($11.76 Million) in capital expenditures ($115.00K). Check SGMO intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sangamo Therapeutics Inc Capital Reinvestment Ratio (2017–2020)
This chart tracks Sangamo Therapeutics Inc's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see SGMO cash flow conversion.
Annual Capital Reinvestment Ratio for Sangamo Therapeutics Inc (2017–2020)
Year-by-year Capital Reinvestment Ratio for Sangamo Therapeutics Inc from 2017 to 2020. See Sangamo Therapeutics Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.09x | $169.88 Million | $14.71 Million | ▼ -92.5% |
| 2018 | 1.16x | $37.15 Million | $43.06 Million | ▲ +245.5% |
| 2017 | 0.34x | $11.18 Million | $3.75 Million | — |